The research in the Oppermann group focuses on drug and target discovery by using systems biology and single-cell approaches in a variety of human diseases including metabolic, inflammatory and malignant diseases. Application of novel single-cell technologies and chemical biology in primary and secondary bone cancers such as multiple myeloma with a focus on epigenetic mechanisms is a key research area of the group.